BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37667154)

  • 21. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.
    Franceschini MC; Ferro P; Canessa PA; Battolla E; Dessanti P; Valentino A; Casolari L; Fontana V; Pezzi R; Fedeli F; Pistillo MP; Roncella S
    Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?
    Lyons-Boudreaux V; Mody DR; Zhai J; Coffey D
    Arch Pathol Lab Med; 2008 Jan; 132(1):23-8. PubMed ID: 18181669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
    Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
    Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.
    Cedrés S; Montero MA; Zamora E; Martínez A; Martínez P; Fariñas L; Navarro A; Torrejon D; Gabaldon A; Ramon Y Cajal S; Felip E
    Clin Transl Oncol; 2014 Sep; 16(9):776-82. PubMed ID: 24323466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidetector CT Findings and Differential Diagnoses of Malignant Pleural Mesothelioma and Metastatic Pleural Diseases in Korea.
    Kim YK; Kim JS; Lee KW; Yi CA; Goo JM; Jung SH
    Korean J Radiol; 2016; 17(4):545-53. PubMed ID: 27390546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
    Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
    Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic utility of D2-40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology.
    Hyun TS; Barnes M; Tabatabai ZL
    Acta Cytol; 2012; 56(5):527-32. PubMed ID: 23075894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
    Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma.
    Goudarzi H; Hida Y; Takano H; Teramae H; Iizasa H; Hamada J
    Biomed Res; 2013 Feb; 34(1):13-21. PubMed ID: 23428976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
    Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
    Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis.
    Gao R; Wang F; Wang Z; Wu Y; Xu L; Qin Y; Shi H; Tong Z
    Medicine (Baltimore); 2019 Apr; 98(14):e14979. PubMed ID: 30946324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening.
    Nakamura A; Hashimoto M; Kodama H; Yuki M; Kondo N; Yamakado K; Tsujimura T; Kijima T; Hasegawa S
    Int J Clin Oncol; 2021 Jan; 26(1):95-103. PubMed ID: 32914367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of primary gastric Burkitt's lymphoma associated with malignant pleural mesothelioma.
    Spaziani E; Di Filippo AR; Valle G; Spaziani M; Francioni P; Caruso G; Tamagnini GT; Mosciatti E; Picchio M; De Cesare A
    Ann Ital Chir; 2023 Mar; 12():. PubMed ID: 36924064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant mesothelioma: A clinicopathological study of 76 cases with emphasis on immunohistochemical evaluation along with review of the literature.
    Patel T; Aswal P
    Indian J Pathol Microbiol; 2021; 64(4):655-663. PubMed ID: 34673582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels.
    Saraya T; Ohkuma K; Fujiwara M; Ishii H
    Medicine (Baltimore); 2022 Jan; 101(1):e28517. PubMed ID: 35029914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
    Hashimoto M; Sato A; Kuroda A; Nakamura A; Nakamichi T; Kondo N; Yuki M; Nabeshima K; Tsujimura T; Hasegawa S
    Gen Thorac Cardiovasc Surg; 2020 Aug; 68(8):820-827. PubMed ID: 31981139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma.
    Fortin M; Cabon E; Berbis J; Laroumagne S; Guinde J; Elharrar X; Dutau H; Astoul P
    Respiration; 2020; 99(1):28-34. PubMed ID: 31655816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.